Evidence map›Paper›PMID 36519447›Full record

Trial reportGut microbes

Gut microbiota differs between treatment outcomes early after fecal microbiota transplantation against recurrent

Shaodong Wei, Martin Iain Bahl, Simon Mark Dahl Baunwall, Jens Frederik Dahlerup, Christian Lodberg Hvas, Tine Rask Licht

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Gut microbes. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Safety and efficacy of fecal microbiota transplantation versus antibiotics for treating clostridioides difficile infection: systematic review and meta-analysis.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Pooled it
  2. Fecal Microbiota Transplantation BeyondJournal of Korean medical science · 2026
    Review
  3. Article
  4. Article
  5. Frontiers in microbiology · 2026
    Article
  6. Gut microbes · 2025
    Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Pathogens (Basel, Switzerland) · 2024
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Shaodong WeiNational Food Institute, Technical University of Denmark, Kgs Lyngby, Denmark.
Martin Iain BahlNational Food Institute, Technical University of Denmark, Kgs Lyngby, Denmark.
Simon Mark Dahl BaunwallDepartment of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus N, Denmark.
Jens Frederik DahlerupDepartment of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus N, Denmark.
Christian Lodberg HvasDepartment of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus N, Denmark.
Tine Rask LichtNational Food Institute, Technical University of Denmark, Kgs Lyngby, Denmark.ORCID 0000-0002-6399-9574
Aarhus University Hospital · DKTechnical University of Denmark · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

AbstarctIn fecal microbiota transplantation (FMT) against recurrent

Indexed as

Clostridioides difficileClostridium InfectionsGastrointestinal MicrobiomeAnti-Bacterial AgentsFecal Microbiota TransplantationHumansTreatment OutcomeVancomycinAnti-Bacterial AgentsVancomycinClostridioides difficilefecal microbiota transplantationfidaxomicingut microbiotavancomycin

Identifiers

PMID36519447
PMCPMC9176232
OpenAlexW4281682105

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.